OakChart

Privia Health Group Inc

PRVAHealthcare·Health Information Services·USA·Mid·NASD·Nov 11 • 3:59 PM ET

24.04-0.33 (-1.35%)
2026-11-12 01:00 CET
Market cap
3,113.71 USD m
Revenue, TTM
2,434.61 USD m
Net income, TTM
34.75 USD m
Free cash flow, TTM
106.94 USD m
EPS diluted, TTM
0.26
P/E
91.10
Compare

Price

PRVA against its 20, 50 and 200-day averages
2050200beatearnings
20.0022.5025.0027.502.2M4.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PRVAclose 24.0420-day 22.7050-day 21.26200-day 22.6624.0452w high52w low

16.6% under the 52-week high of 28.82 on 16 Jul 2026. 52-week low 18.92 on 24 Sep 2026. Last 15 sessions, 20.3% high to low

Volume 0.65× normal · the line is the 50-bar volume average

Profile

PRVA
52-week range, 52% of the way up
18.9228.82

Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

IndexRUT
Employees1226
IPOApr 29, 2021
Beta0.73
ATR, 14d0.77
Rel volume0.65
Short float3.28%
Insider own7.11%
Inst own89.60%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap3.07B
Enterprise Value2.69B
Income34.75M
Sales2.43B
Book/sh6.38
Cash/sh3.49
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees1226
IPOApr 29, 2021

Ratios

P/E91.10
Forward P/E54.28
PEG1.14
P/S1.26
P/B3.77
P/C6.88
P/FCF28.72
EV/EBITDA42.17
EV/Sales1.11
Quick Ratio1.63
Current Ratio1.63
Debt/Eq0.01
LT Debt/Eq0.01
Option/ShortYes / Yes

Earnings

EPS (ttm)0.26
EPS next Y0.44
EPS next Q0.10
EPS this Y54.19%
EPS next Y59.58%
EPS next 5Y47.60%
EPS past 3/5Y- -9.67%
Sales past 3/5Y16.10% 21.04%
EPS Y/Y TTM84.88%
Sales Y/Y TTM19.19%
EPS Q/Q90.62%
Sales Q/Q13.19%
EarningsNov 05 BMO
EPS/Sales Surpr.10.50% 7.57%

Ownership

Insider Own7.11%
Insider Trans-6.08%
Inst Own89.60%
Inst Trans-2.09%
ROA2.38%
ROE4.56%
ROIC4.23%
Gross Margin9.38%
Oper. Margin2.10%
Profit Margin1.43%
SMA205.89%
SMA5013.06%
SMA2006.11%
Trades-

Technical

Shs Outstand127.77M
Shs Float118.68M
Short Float3.28%
Short Ratio3.09
Short Interest3.90M
52W High28.82 -16.59%
52W Low18.92 27.09%
Volatility4.42% 3.19%
ATR (14)0.77
RSI (14)66.42
Beta0.73
Rel Volume0.65
Avg Volume1.26M
Volume821,234

Performance

Perf Week7.32%
Perf Month11.04%
Perf Quarter10.48%
Perf Half Y6.23%
Perf YTD1.39%
Perf Year-1.15%
Perf 3Y10.33%
Perf 5Y-24.71%
Perf 10Y-
Recom1.17
Target Price31.35
Prev Close24.37
Price24.04
Change %-1.35%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jan 09, 2026InitiatedRRBC Capital MktsOutperform$31+29.0%
Nov 13, 2025InitiatedBBMO Capital MarketsOutperform$30+24.8%
Jan 10, 2025InitiatedNNeedhamBuy$25+4.0%
Dec 16, 2024InitiatedMMacquarieOutperform
Oct 11, 2024InitiatedKKeyBanc Capital MarketsOverweight$23-4.3%
May 30, 2024InitiatedRRobert W. BairdOutperform$23-4.3%
Apr 22, 2024InitiatedCCitigroupBuy$25+4.0%
Mar 06, 2024InitiatedBBarclaysEqual Weight$22-8.5%
Feb 26, 2024ResumedJJefferiesBuy$33 → $25+4.0%
Feb 22, 2024DowngradeBBofA SecuritiesBuy → Neutral$21-12.6%

Peers

Mkt cap
TickerCompanyMkt cap
AGLAgilon Health Inc1.93B
ASTHAstrana Health Inc1.63B
EVHEvolent Health Inc564.40M
PIIIP3 Health Partners Inc18.95M
MDPediatrix Medical Group Inc2.46B
ALHCAlignment Healthcare Inc1.61B
HCATHealth Catalyst Inc108.90M
UNHUnitedhealth Group Inc361.04B
CLOVClover Health Investments Corp2.64B
INNVInnovAge Holding Corp1.30B

Insider trading

latest 14 of 84
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Mountcastle DavidEVP & Chief Financial OfficerJul 09 '26Sale27.6721,275588,679164,853Jul 13 04:01 PM
Mountcastle DavidOfficerJul 09 '26Proposed Sale27.6721,275588,603Jul 09 05:13 PM
Mountcastle DavidEVP & Chief Financial OfficerJul 07 '26Sale27.5760016,542186,128Jul 09 04:37 PM
Morris Matthew ShawnDirectorJul 02 '26Option Exercise2.0059,037118,074135,688Jul 07 04:08 PM
Morris Matthew ShawnDirectorJul 06 '26Option Exercise2.0053,722107,444130,373Jul 07 04:08 PM
Morris Matthew ShawnDirectorJul 02 '26Sale27.3359,0371,613,48176,651Jul 07 04:08 PM
Morris Matthew ShawnDirectorJul 06 '26Sale27.2453,7221,463,38768,188Jul 07 04:08 PM
Mountcastle DavidEVP & Chief Financial OfficerJul 02 '26Sale27.5024,734680,185186,728Jul 07 04:06 PM
Mountcastle DavidOfficerJul 07 '26Proposed Sale27.5760016,539Jul 07 03:57 PM
Mountcastle DavidOfficerJul 02 '26Proposed Sale27.5024,734680,188Jul 02 04:17 PM
Morris Matthew ShawnDirectorJul 01 '26Option Exercise2.0082,675165,350159,326Jul 02 04:04 PM
Morris Matthew ShawnDirectorJun 30 '26Option Exercise2.0052,823105,646129,474Jul 02 04:04 PM
Morris Matthew ShawnDirectorJul 01 '26Sale26.7082,6752,207,72876,651Jul 02 04:04 PM
Morris Matthew ShawnDirectorJun 30 '26Sale25.7252,8231,358,60876,651Jul 02 04:04 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.45B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.1000.0910.100656.96610.7213
2026Q22026-08-060.0700.0670.069632.63597.3313
2026Q12026-05-070.0200.0750.023603.85560.9914
2025Q42026-02-260.0700.0300.070541.17516.1513
2025Q32025-11-060.0500.0540.053580.42492.713
2025Q22025-08-070.0200.0500.021521.15467.0413
2025Q12025-05-080.0300.0460.033480.1452.8413
2024Q42025-02-270.0300.0500.035460.9420.7915
2024Q32024-11-070.0300.0480.028437.92414.2315
2024Q22024-08-080.0300.0450.028422.33411.513
2024Q12024-05-090.0200.0480.024415.24393.5514
2023Q42024-02-270.0200.0420.023440.83427.1113
2023Q32023-11-030.0500.0490.045417.28410.5112
2023Q22023-08-030.0600.0560.058413.35392.0913
2023Q12023-05-040.1600.0620.059386.28378.1515
2022Q42023-02-280.1400.0120.143364.42332.6413

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY0.301-0.296817.37-
2021FY-1.830-1.812-1.746966.22917.73
2022FY-0.080-0.253-0.0781,3571,326
2023FY0.1900.2060.1851,6581,644
2024FY0.1100.1310.1151,7361,697
2025FY0.1800.1320.1802,1232,098
2026FY-0.278--2,518
2027FY-0.443--2,752
2028FY-0.579--3,074
2029FY-0.760--3,296
2030FY-0.907--3,611

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0617120633.69602.68656.9
2026Q4S2026-11-0516120634.11602.68656.9
2026Q4S2026-10-301710609.27592.6656.9
2026Q4S2026-10-261710609.27592.6656.9
2026Q4S2026-10-211711609.27592.6656.9
2026Q4S2026-10-201712609.27592.6656.9
2026Q4S2026-10-091756609.27592.6656.9
2026Q4S2026-10-051756609.28592.6656.9
2026Q4S2026-10-021756609.28592.6656.9
2026Q4S2026-09-251746605.55592.6630.09
2026Q4S2026-09-151846605.43592.6630.09
2026Q4S2026-08-121847605.43592.6630.09
2026Q4S2026-08-101856606.36592.6630.09
2026Q4S2026-08-071856606.49592.6630.09

Estimate history

EPS, annual-0.0290.0780.296-1.746-0.0780.1850.1150.1780.2639
Period20182019202020212022202320242025TTM
EPS, quarterly0.0280.0350.0330.0210.0530.070.0230.0690.102
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual657.609786.36817.075966.221356.661657.7371736.392122.8422434.61
Period20182019202020212022202320242025TTM
Sales, quarterly437.921460.9480.097521.153580.419541.173603.847632.63656.96
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual-105.711105.711107.838114.691118.217120.309123.605127.768
Period20182019202020212022202320242025MRQ
Shares, quarterly119.953120.309121.391122.673122.868123.605125.689126.29127.768
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,434.612,122.841,736.391,657.741,356.66966.22817.08786.36657.61
Cost of Goods Sold Incl. D&A2,206.221,923.321,566.811,502.771,226.45905.02736.34719.32602.22
Gross Profit228.39199.52169.59154.97130.2161.2080.7467.0555.39
Selling, General and Administrative Excl. Other177.38165.29152.60134.32149.33278.6355.3650.9853.23
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income51.0134.2316.9820.65-19.12-217.4425.3816.062.15
Interest Expense0.000.000.000.00-1.071.926.916.42
Unusual Expense0.000.000.000.000.000.000.000.000.00
Net Income Before Taxes61.7043.9427.8729.02-18.58-218.5123.469.15-4.26
Income Taxes23.0714.2110.837.99-6.52-27.86-7.441.21-0.08
Consolidated Net Income38.6229.7317.0421.03-12.06-190.6530.907.95-4.19
Net Income From Continuing Operations34.7522.9214.3823.08-8.59-188.2331.248.24-3.04
Net Income34.7522.9214.3823.08-8.59-188.2331.248.24-3.04
EPS (Recurring)0.260.180.110.19-0.08-1.750.300.08-0.03
EPS (Basic, Before Extraordinaries)0.280.190.120.20-0.08-1.750.300.08-0.03
EPS (Diluted)0.260.180.110.19-0.08-1.750.300.08-0.03
EBITDA63.8144.1424.2527.18-14.55-214.9727.2217.493.23
Non-Operating Income (Expense)10.689.7010.898.370.540.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense48.0056.1444.7829.3153.21185.080.360.151.39
Price To Earnings Ratio92.3592.35190.9275.34-----
Price To Sales Ratio1.071.441.411.731.852.89---
Gross Margin9.389.409.779.359.606.339.888.538.42
Operating Margin2.101.610.981.25-1.41-22.503.112.040.33
Net Margin1.431.080.831.39-0.63-19.483.821.05-0.46
Shares Outstanding127.77123.60120.31118.22114.69107.84105.71105.71-
Market Capitalization3,113.713,113.712,346.022,719.012,595.732,755.132,822.22--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue656.96632.63603.85541.17580.42521.15480.10460.90
Cost of Goods Sold Incl. D&A592.03573.20546.82494.18519.41473.49436.24414.76
Gross Profit64.9359.4357.0347.0061.0047.6643.8646.13
Selling, General and Administrative Excl. Other44.3947.6649.6135.7246.6044.3238.6440.89
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income20.5411.777.4211.2814.403.345.225.25
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes22.2716.759.3113.3716.675.748.158.02
Income Taxes7.677.025.602.796.872.462.102.65
Consolidated Net Income14.599.733.7110.599.813.296.055.37
Net Income From Continuing Operations13.499.053.069.156.862.694.224.40
Net Income13.499.053.069.156.862.694.224.40
EPS (Recurring)0.100.070.020.070.050.020.030.03
EPS (Basic, Before Extraordinaries)0.110.070.020.070.060.020.040.04
EPS (Diluted)0.100.070.020.070.050.020.030.03
EBITDA24.0415.1310.7013.9417.175.927.127.08
Non-Operating Income (Expense)1.724.981.892.092.272.412.932.77
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.0915.3217.324.2814.9914.8914.0512.07
Price To Earnings Ratio92.35153.34115.95166.97213.00186.08196.24190.92
Price To Sales Ratio1.071.441.201.461.571.551.591.42
Gross Margin9.889.399.448.6810.519.159.1410.01
Operating Margin3.131.861.232.082.480.641.091.14
Net Margin2.051.430.511.691.180.520.880.95
Shares Outstanding127.77126.29125.69123.60122.87122.67121.39120.31
Market Capitalization3,113.713,242.292,544.262,916.383,055.982,804.162,705.522,346.02

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments479.69491.15389.51347.99320.5884.6346.89-
Short Term Receivables400.90316.18290.77189.60117.4099.1277.34-
Inventories0.000.000.000.000.000.000.00-
Other Current Assets30.4127.5020.5214.378.706.335.37-
Total Current Assets911.00834.82700.80551.96446.68190.08129.60-
Net Property, Plant & Equipment9.306.078.9411.4714.144.815.62-
Total Investments and Advances0.000.000.000.000.000.000.00-
Long-Term Note Receivable-----0.004.03-
Intangible Assets425.76251.42246.38184.32187.68124.64125.28-
Deferred Tax Assets30.5036.3844.3251.8742.6410.950.00-
Other Assets21.0417.098.584.684.524.475.67-
Total Assets1,397.611,145.781,009.02804.31695.65334.96270.20-
Short Term Debt Incl. Current Port. of LT Debt2.202.553.043.013.770.883.38-
Accounts Payable477.49374.36333.96215.16143.68112.0582.79-
Other Current Liabilities88.8372.2349.9546.1143.0134.0229.05-
Total Current Liabilities568.52449.15386.95264.27190.46146.94115.22-
Long Term Debt7.333.045.258.4942.7332.7839.73-
Provision for Risks Charges0.000.000.000.000.000.000.00-
Deferred Tax Liabilities28.239.999.1211.509.285.992.88-
Other Liabilities2.580.150.311.003.005.594.92-
Total Liabilities606.66462.33401.63285.26245.47191.31162.75-
Non-Equity Reserves0.000.000.000.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00-
Common Equity737.22635.18561.44499.09426.87146.75110.21-
Total Shareholders Equity737.22635.18561.44499.09426.87146.75110.21-
Accumulated Minority Interest53.7348.2645.9519.9523.31-3.10-2.76-
Total Equity790.94683.45607.39519.05450.18143.65107.46-
Total Liabilities & Stockholders Equity1,397.611,145.781,009.02804.31695.65334.96270.20-
Book Value Per Share5.965.284.754.353.961.391.04-
Tangible Book Value Per Share2.523.192.672.742.220.21-0.14-
Full-Time Employees1,2261,1401,102964810559--
Price to Book Ratio3.823.814.995.506.546.86--
Return on Assets1.801.342.55-1.14-36.5310.33--
Return on Equity3.342.404.35-1.85-65.6324.32--
Return on Invested Capital3.082.254.07-1.69-40.0817.405.50-
Quick Ratio1.601.861.812.092.351.291.12-
Current Ratio1.601.861.812.092.351.291.12-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income38.6229.7317.0421.03-12.06-190.6530.907.95-4.19
Depreciation12.809.917.276.534.572.461.831.431.07
Other Funds (Non Cash)70.8071.0756.6837.1068.05253.690.620.542.09
Funds from Operations127.64121.5789.8172.1253.5537.0925.5210.63-1.29
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-19.5741.8319.478.66-6.3517.9713.3713.736.54
Cash from Operating Activities108.07163.40109.2880.7847.2055.0638.8924.365.25
Capital Expenditures-1.13-1.20-5.02-0.11-0.10-0.55-0.38-5.71-0.22
Net Assets From Acquisitions-114.19-180.37-6.96-48.550.00-32.230.000.000.00
Sale of Fixed Assets and Businesses2.560.001.650.660.120.000.000.000.06
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments-0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-112.75-181.57-10.32-48.010.02-32.77-0.38-5.71-0.17
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock10.968.052.688.7413.45214.820.110.000.11
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock10.968.052.688.7413.45214.820.110.000.11
Proceedsfrom Stock Options0.000.000.000.000.00210.990.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.00-33.25-0.88-0.88-10.8715.25
Change in Long Term Debt0.000.000.000.00-33.25-0.88-0.88-10.8715.25
Issuance of Long Term Debt0.000.000.000.000.000.0010.0034.3815.25
Reduction of Long Term Debt0.000.000.000.00-33.25-0.88-10.88-45.250.00
Net Financing Active Other Cash Flow-1.34-1.340.000.000.000.000.000.000.00
Other Financing Activities Uses-1.34-1.340.000.000.000.000.000.000.00
Cash from Financing Activities9.616.702.688.74-19.80213.66-0.77-10.8715.36
Net Change in Cash4.93-11.46101.6441.5227.41235.9437.747.7820.44
Free Cash Flow106.94162.20104.2680.6747.0954.5138.5118.655.03
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow24.4318.8423.5535.6053.3851.18---
Deferred Taxes & Investment Tax Credit-10.878.827.46-7.00-28.41-7.830.72-0.26

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments446.28412.20419.52479.69441.35390.13
Short Term Receivables623.58574.16513.68400.90499.04443.99
Inventories0.000.000.000.000.000.00
Other Current Assets29.6938.9132.8230.4130.5348.84
Total Current Assets1,099.561,025.27966.02911.00970.93882.96
Net Property, Plant & Equipment8.558.318.699.306.336.87
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets431.08434.44422.63425.76339.75342.36
Deferred Tax Assets0.000.000.0030.5017.0523.71
Other Assets24.5320.5620.5521.0416.9316.65
Total Assets1,563.721,488.581,417.891,397.611,350.991,272.54
Short Term Debt Incl. Current Port. of LT Debt2.112.072.112.202.562.50
Accounts Payable580.70549.86529.28477.49505.90467.07
Other Current Liabilities91.5682.5269.9188.8374.4565.28
Total Current Liabilities674.36634.44601.30568.52582.91534.85
Long Term Debt6.156.676.917.333.674.14
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities3.943.740.2528.23--
Other Liabilities6.355.663.532.581.640.00
Total Liabilities690.80650.51611.99606.66588.23539.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity815.72782.33753.06737.22709.12682.86
Total Shareholders Equity815.72782.33753.06737.22709.12682.86
Accumulated Minority Interest57.2055.7452.8453.7353.6450.69
Total Equity872.91838.07805.90790.94762.76733.55
Total Liabilities & Stockholders Equity1,563.721,488.581,417.891,397.611,350.991,272.54
Book Value Per Share6.386.195.995.965.775.57
Tangible Book Value Per Share3.012.752.632.523.012.78
Full-Time Employees---1,226--
Price to Book Ratio3.824.293.454.114.474.23
Return on Assets2.382.041.671.801.461.26
Return on Equity4.563.843.083.342.742.32
Return on Invested Capital1.641.150.401.230.960.39
Quick Ratio1.631.621.611.601.671.65
Current Ratio1.631.621.611.601.671.65

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income14.599.733.7110.599.813.29
Depreciation3.503.363.282.662.772.58
Other Funds (Non Cash)14.0319.4021.9215.4518.9818.85
Funds from Operations32.3333.6431.4430.2338.2225.68
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.40-32.54-80.9197.2713.78-17.71
Cash from Operating Activities28.941.10-49.47127.5051.997.97
Capital Expenditures-1.07-0.03-0.030.00-1.200.00
Net Assets From Acquisitions0.00-11.43-11.44-91.310.00-89.06
Sale of Fixed Assets and Businesses0.352.210.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.00--0.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.72-9.25-11.47-91.31-1.20-89.06
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock5.870.830.773.490.431.88
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock5.870.830.773.490.431.88
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.00-1.340.000.00
Other Financing Activities Uses0.000.000.00-1.340.000.00
Cash from Financing Activities5.870.830.772.150.431.88
Net Change in Cash34.08-7.32-60.1638.3351.23-79.20
Free Cash Flow27.871.07-49.49127.5050.797.97
Price to Free Cash Flow24.4326.1219.6819.0629.2932.17

Revenue breakdown

Capitated2024: 212.99M 2025: 308.46M
Care Management Fee (PMPM)2024: 64.07M 2025: 73.14M
FFS-Administrative Services2024: 125.43M 2025: 137.02M
FFS-Patient Care2024: 1.15B 2025: 1.36B
Other2024: 8.55M 2025: 9.18M
Shared Savings2024: 179.20M 2025: 234.82M
United States2024: 1.74B 2025: 2.12B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.28%3.9M118.7M1.23M
2026-10-154.22%5.0M118.7M1.28M
2026-09-304.89%5.8M118.7M1.22M
2026-09-154.13%4.9M118.7M1.22M
2026-08-314.58%5.5M119.2M1.18M
2026-08-144.44%5.3M119.2M1.17M
2026-07-313.22%3.8M119.2M1.14M
2026-07-153.14%3.7M117.6M1.07M
2026-06-303.17%3.7M117.5M1.03M
2026-06-152.55%3.0M117.4M943.22K
2026-05-292.83%3.3M117.5M917.27K
2026-05-152.89%3.4M117.5M959.91K
2026-04-302.72%3.2M117.7M856.64K
2026-04-152.31%2.7M117.2M860.57K
2026-03-312.15%2.5M115.4M824.63K
2026-03-132.04%2.4M115.4M785.52K
2026-02-272.15%2.5M115.4M744.73K
2026-02-132.31%2.7M114.7M692.11K
2026-01-302.31%2.7M114.7M746.57K
2026-01-152.23%2.6M114.7M722.41K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.5010.1013.700.005.9740.000.000.904-0.1570.006
call15.007.6011.200.004.7610.000.000.877-0.1480.008
call17.505.108.700.003.7410.000.000.839-0.1350.009
call20.003.904.304.601.0652440.000.783-0.1170.011
call22.501.501.902.120.6771,3630.000.647-0.1470.014
call25.000.050.350.250.4762,8510.000.413-0.0710.015
call27.500.000.950.980.9232230.000.195-0.0540.010
call30.000.002.150.211.26833.000.000.154-0.0640.009
call32.500.000.950.001.5600.000.000.132-0.0710.008
call35.000.002.150.001.7450.000.000.107-0.0680.007
call37.500.002.150.001.9680.000.000.098-0.0720.006
put12.500.002.150.304.3471.000.00-0.096-0.1560.006
put15.000.002.150.203.4021.000.00-0.123-0.1470.008
put17.500.002.150.052.5924.000.00-0.161-0.1330.009
put20.000.001.000.521.86212.000.00-0.217-0.1150.011
put22.500.002.300.402.1006.000.00-0.353-0.1440.014
put25.000.003.100.601.7180.000.00-0.587-0.0690.015
put27.501.354.600.001.5830.000.00-0.805-0.0510.010
put30.004.006.900.001.8420.000.00-0.846-0.0610.009
put32.506.409.900.002.5920.000.00-0.868-0.0670.008
put35.009.0012.400.002.9060.000.00-0.882-0.0720.007
put37.5011.4014.900.003.1840.000.00-0.892-0.0760.007

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-30SCHEDULE 13GSEC
2026-10-07SCHEDULE 13G/ASEC
2026-09-08SCHEDULE 13DSEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-033Initial statement of beneficial ownership of securities2026-09-01SEC
2026-08-188-KCurrent report2026-08-12SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-29SCHEDULE 13G/ASEC
2026-07-134Statement of changes in beneficial ownership of securities2026-07-09SEC
2026-07-09144Filing for proposed sale of securities under Rule 144.SEC
2026-07-094Statement of changes in beneficial ownership of securities2026-07-07SEC
2026-07-07144Filing for proposed sale of securities under Rule 144.SEC
2026-07-074Statement of changes in beneficial ownership of securities2026-07-02SEC
2026-07-078-KCurrent report2026-07-06SEC
2026-07-074Statement of changes in beneficial ownership of securities2026-07-02SEC
2026-07-02144Filing for proposed sale of securities under Rule 144.SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-26144Filing for proposed sale of securities under Rule 144.SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-07006.57M6
2026-06005.62M4
2026-05003.47M7
2026-0400116.05K1
2026-03004.59M13
2026-0200935.21K4
2026-010000
2025-1200939.20K2
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.16.98%
Durable Capital Partners LP9.23%
FMR LLC5.35%
VANGUARD PORTFOLIO MANAGEMENT LLC5.22%
Rubicon Founders LLC4.74%
VANGUARD CAPITAL MANAGEMENT LLC4.09%
STATE STREET CORP3.89%
Van Berkom & Associates Inc.2.89%
GEODE CAPITAL MANAGEMENT, LLC2.51%
RIVERBRIDGE PARTNERS LLC2.27%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF5.66%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.85%
iShares Russell 2000 ETF2.50%
VANGUARD SMALL-CAP INDEX FUND2.06%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.19%
VANGUARD EXTENDED MARKET INDEX FUND1.08%
Fidelity Small Cap Index Fund1.05%
Fidelity Small Cap Growth Fund1.02%
Select Health Care Services Portfolio0.89%
iShares Russell 2000 Growth ETF0.89%

OakChart. PRVA. Cached 15 minutes.